Physician profile
Calvin D Baize
NPI 1477644516
$483.55
in general payments reported to CMS, 2019-2025
13 companies · $55.66 in 2025
The $55.66 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.79 · 2021: $49.06 · 2022: $255 · 2023: $19.14 · 2024: $33.96 · 2025: $55.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $198.10 | 2021-2022 | |
| Treace Medical Concepts, INC. | $76.49 | 2022-2024 | |
| Djo, LLC | $36.81 | 2025 | Chattanooga |
| Stryker Corporation | $32.95 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.05 | 2022 | |
| Horizon Therapeutics Plc | $19.14 | 2023 | Krystexxa |
| Kerecis Limited | $18.85 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Averitas Pharma INC. | $16.82 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $15.38 | 2019 | |
| Smith+Nephew, INC. | $13.47 | 2021 | |
| Cardiovascular Systems INC. | $13.03 | 2022 | |
| Melinta Therapeutics, LLC | $12.33 | 2019 | |
| Arteriocyte Medical Systems, INC. | $10.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Baize listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.